Merck & Co., Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MRK | AZN | PFE | 0QYQ.IL | JNJ.F | GSK | |
|---|---|---|---|---|---|---|
| Market cap | 370.96B | 293.14B | 175.50B | 215.56B | 593.52B | 102.53B |
| P/E (TTM) | 151.9 | 26.7 | 44.0 | 39.8 | 43.5 | 17.8 |
| Forward P/E | 16.7 | 16.7 | 10.6 | — | — | 10.3 |
| Price/book | 8.9 | 5.7 | 2.1 | 10.2 | 8.2 | 4.1 |
| Dividend yield | 2.26% | 1.69% | 5.59% | 3.81% | 2.00% | 3.55% |
| 1-year change | +75.29% | +12.81% | +23.90% | +38.91% | +47.99% | +8.60% |
| Today | +3.93% | +2.79% | +2.63% | +0.58% | −0.20% | +5.03% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All MRK news ›Lonza Expanding U.S. CDMO Footprint with Purchase of Five Merck KGaA Sites
Lonza plans to more than double its U.S. footprint of contract development and manufacturing organization (CDMO) sites by agreeing to acquire five such sites in the U.S. from Merck KGaA, Darmstadt, Germany, in a deal the companies would…
More from 1 other outlet
Merck & (MRK): Q3 2026 net income falls to $5.07B; $6.0B notes issued
Q3 2026 10-Q: $5.07B net income vs $5.79B prior year; $6.0B notes issued May 2026, Welireg approval milestones noted. Plus members following MRK got this by push and email at 16:14:21 ET - 1.6s after publication. Written by Quantisnow AI…
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Merck & Co., Inc. (MRK) And Encourages Shareholders to Reach Out
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int The National Law Review Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Merck & Co., Inc. (MRK) And Encourages Shareholders to Reach…
Lanza acquires Merck's U.S. CDMO business...Securing ADC and viral vector hubs
[Newsworks = Reporter Kim Sang-woo] Lonza, the world's largest biotech contract development and manufacturing organization (CDMO), is acquiring five U.S. CDMO facilities of the German company Merck KGaA. Lonza's U.S. CDMO production sites…
Merck to divest CDMO business across five US sites to Lonza
Merck has signed a definitive agreement to sell its CDMO business to Lonza for a mid-triple-digit million-euro sum, with the transaction expected to complete in mid-2027. Merck has agreed to divest its contract development and…
More from 1 other outlet
Biopharma likely to climb higher after ‘blue wave,’ analysts say
Historical data suggests the sector outperforms after midterm elections. And Democrats, newly in control of Congress, have “bigger fish to fry” than drug pricing, analysts said. The midterm elections have swung control of U.S. Congress…
China's high-quality development: A Merck China perspective
CGTN China's high-quality development: A Merck China perspective Editor's Note: As Shanghai hosts the 9th China International Import Expo (CIIE) from November 5 to 10, what opportunities will China's evolving market offer to multinational
Lonza buys Merck CDMO in Germany to double U.S. footprint as Korea rivals race
Deal adds five U.S. sites as Samsung Biologics and Celltrion accelerate global capacity grabs Lonza, the world's No. 1 biopharmaceutical CDMO company, is expanding its U.S. production foothold and bulking up. Korean corporations Samsung…
MSD’s non-oncology sales set to double as Keytruda faces patent cliff
Pharmaceutical Technology Unlock FREE Access to Premium Content Discover exclusive forecasts, analyst insights, and in-depth pharmaceutical industry analysis spanning drug development, manufacturing, regulation, and global healt
Moderna Climbs 5% Ahead of Earnings, Pfizer Eases Despite Raised Outlook, Merck Slides 2% Amid New Phase 3 Trial
Moderna surges on pre-earnings momentum, Pfizer dips after beating estimates and raising guidance, and Merck drops despite launching a new trial. When stock prices and headlines point in opposite directions across the sector, something…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com106
- marketbeat.com34
- themarketsdaily.com27
- seekingalpha.com20
- defenseworld.net19
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.